CClinicalTrials.gg
CompletedNCT03921619Updated Nov 9, 2021

Sling Use and Functional Mobility in a Geriatric Population

An interventional study of Shoulder Sling in Mobility Limitation, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-09.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Shoulder slings are commonly worn after shoulder surgery. In geriatric patients, painstaking care is taken to reduce any factors that may increase the chance of experiencing a fall. Currently, it is not understood if wearing a sling affects someone's general gait and balance.

Read the detailed description

Following many shoulder operations, patients are immobilized in an bulky sling with non-weight bearing restrictions for periods of up to 6 weeks. This is necessary to allow for soft tissue healing particularly following repair of rotator cuff tears and shoulder replacement surgeries, two common procedures performed in the elderly population. Previous studies have shown that natural arm swing plays an essential role in maintaining balance and normal gait patterns. Decreased functional mobility and gait impairment has been shown to increase the risk of falls, mortality, and morbidity in an elderly population. However, following upper extremity surgery requiring the use of a sling, targeted therapy for gait and balance training is rarely prescribed. Consequently, the investigators wish to assess whether or not sling use impacts functional mobility test scores in an elderly population. The aim of this project is to maximize perioperative functionality in these patients in efforts to prevent any unanticipated secondary injury.

02

Conditions studied

  • Mobility Limitation

Browse trials for

03

In context

Mobility Limitation

317 studies on the registry are indexed under Mobility Limitation; 97 are open to participants now.

This study's enrollment of 50 is close to the median of 46 across 265 interventional studies indexed under Mobility Limitation.

Browse Mobility Limitation studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Greater than or equal to 65 years of age

Exclusion criteria

Exclusion Criteria:

  • Younger than 65 years of age
  • Pre-existing cognitive impairment
  • Pre-existing mobility impairment
  • Pre-existing symptomatic upper or lower extremity disease
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • No intervention
    No Sling

    Participants will perform the balance tests without any added equipment.

  • Experimental
    Sling (Dominant)

    Participants will perform the balance tests with a sling on the dominant arm.

    Device: Shoulder Sling

Interventions

  • DeviceShoulder Sling

    soft shoulder sling that is placed around the forearm, with a strap draped over the shoulder

06

What researchers measure

Primary outcomes

  1. Tinetti Test

    Performance-oriented mobility assessment: Components are balance \& gait. Patient will be seated in a hard, armless chair and be assessed for balance with all of the following: sitting balance, rising from chair, attempting to rise, immediate standing balance (first 5 sec), standing balance, balance while being nudged, balance with eyes closed, turning 360 degrees, and sitting down. Scored out of 16. The gait portion assesses hesitancy, step length \& height, foot clearance, step symmetry, step continuity, path, trunk, and walking time. Scored out of 12. Total score out of 28. If score is ≤18, risk of falls is high. If score is 19-23, risk of falls is moderate. If score is ≥24, risk of falls is low.

    Time frame: 30 seconds

  2. Timed Up & Go Test

    Timed stand, walk, and sit test to assess mobility

    Time frame: 30 seconds

  3. Edmonton Frail Scale

    Global assessment of patient vulnerability: Domains to be assessed are cognition (clock drawing), general health status (hospitalizations in last year \& describing own health), functional independence (how many ADL's require help), social support, medication use (5 or more on a regular basis, adherence to regimen), nutrition (weight loss), mood, continence, and functional performance (timed rising from chair and walking). Scored out of 17, higher scores associated with higher frailty. Scoring : 0 - 5 = Not Frail; 6 - 7 = Vulnerable; 8 - 9 = Mild Frailty; 10-11 = Moderate Frailty; 12-17 = Severe Frailty;

    Time frame: 1 minute

  4. Sling / Fall Questionnaire

    General questions about sling use and experiencing a fall. There is no scale associated with this questionnaire.

    Time frame: 1 minute

07

Study locations

1 site
  • UAB Hospital Highlands
    Birmingham, Alabama 35205, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03921619
Lead sponsor
University of Alabama at Birmingham
Responsible party
Amit Momaya (Assistant Professor, Orthopaedic Surgery, University of Alabama at Birmingham) — Principal investigator
First posted
Apr 19, 2019
Start date
Feb 15, 2020
Primary completion
Jul 31, 2021
Completion
Oct 30, 2021
Last update
Nov 9, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion